Paradigm Capital Management Inc Axogen, Inc. Transaction History

Paradigm Capital Management Inc

  • $2.21 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 20, 2021
SELL
$11.5 - $17.96 $291,755 - $455,645
-25,370 Closed
0 $0
Q3 2020

Oct 20, 2020
SELL
$10.62 - $13.12 $269,004 - $332,329
-25,330 Reduced 49.96%
25,370 $295,000
Q3 2019

Nov 07, 2019
BUY
$12.09 - $20.46 $612,963 - $1.04 Million
50,700 New
50,700 $633,000

Others Institutions Holding AXGN

# of Institutions
162
Shares Held
36.6M
Call Options Held
230K
Put Options Held
400
View Full List

About Axogen, Inc.

AXGN Quotes by TradingView
  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $688M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Paradigm Capital Management Inc Portfolio

Follow Paradigm Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email